Showing results (1391-1400 of 1,731) with videos related to

Sort By:
Pageof 174
Pathology, Research and Practice|July 25, 2022
Large-scale human tissue analysis identifies Uroplakin 1a as a putative diagnostic marker for urothelial cancerViktor Reiswich, Steffi Könemann, Maximilian Lennartz, et al.
Journal of American College Health : J of ACH|June 29, 2018
Meningococcal serogroup B outbreak response University of Wisconsin-MadisonAlicia M Ritscher, Nancy Ranum, Joel D Malak, et al.
Infection|February 7, 2024
Persistent immune abnormalities discriminate post-COVID syndrome from convalescenceJulia Sbierski-Kind, Stephan Schlickeiser, Svenja Feldmann, et al.
Journal of Extracellular Biology|February 23, 2026
Extracellular Vesicle Properties and Functions Are Defined by the Originating Cell's Fitness StatusStephanie Leyk, Imke Liebold, Clarissa Lanzloth, et al.
The Journal of Investigative Dermatology|July 7, 2026
Clinical and molecular improvements in pediatric patients with atopic dermatitis treated with dupilumab: an analysis from the TREATKids registryMelina Fonfara, Dora Stölzl, Jan Hartmann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 10, 2016
Selection of an early biomarker for vascular normalization using dynamic contrast-enhanced ultrasonography to predict outcomes of metastatic patients treated with bevacizumabN Lassau, B Coiffier, M Kind, et al.
Environmental Health Perspectives|March 23, 2004
Overview on the application of transcription profiling using selected nephrotoxicants for toxicology assessmentJeffrey A Kramer, Syril D Pettit, Rupesh P Amin, et al.
BMC Biotechnology|May 22, 2013
Factors influencing the efficiency of generating genetically engineered pigs by nuclear transfer: multi-factorial analysis of a large data setMayuko Kurome, Ludwig Geistlinger, Barbara Kessler, et al.
Nature Medicine|May 26, 2022
Pembrolizumab in soft-tissue sarcomas with tertiary lymphoid structures: a phase 2 PEMBROSARC trial cohortA Italiano, A Bessede, M Pulido, et al.
Investigative Radiology|July 4, 2014
Validation of dynamic contrast-enhanced ultrasound in predicting outcomes of antiangiogenic therapy for solid tumors: the French multicenter support for innovative and expensive techniques studyNathalie Lassau, Julia Bonastre, Michèle Kind, et al.
Pageof 174